-
1دورية أكاديمية
المساهمون: Tri Rini Nuringtyas, Gadjah Mada University, Lisna Hidayati, Gadjah Mada University, Nastiti Wijayanti, Gadjah Mada University, Faculty of Biology, Gadjah Mada University
المصدر: BERITA BIOLOGI; Vol 21, No 2 (2022): Berita Biologi; 101 - 109 ; 2337-8751 ; 0126-1754
مصطلحات موضوعية: immunomodulator, phagocytosis activity, cytotoxicity, G. versteegiii, macrophage, and NO
الإتاحة: https://doi.org/10.14203/beritabiologi.v21i2.4136Test
https://e-journal.biologi.lipi.go.id/index.php/berita_biologi/article/view/4136Test -
2دورية أكاديمية
المؤلفون: Adryan Fristiohady, Wa Ode Siti Zubaydah, Wahyuni Wahyuni, Mirda Mirda, Saripuddin Saripuddin, Rina Andriani, La Ode Muhammad Julian Purnama, Sahidin Sahidin
المصدر: Borneo Journal of Pharmacy, Vol 2, Iss 2, Pp 35-40 (2019)
مصطلحات موضوعية: effervescent granule, wualae fruit, phagocytosis activity, Pharmacy and materia medica, RS1-441
وصف الملف: electronic resource
العلاقة: http://journal.umpalangkaraya.ac.id/index.php/bjop/article/view/868Test; https://doaj.org/toc/2621-4814Test
-
3دورية أكاديمية
المؤلفون: Erica Andersen-Nissen (8881685), Andrew Fiore-Gartland (849286), Lamar Ballweber Fleming (10305199), Lindsay N. Carpp (8048906), Anneta F. Naidoo (10305202), Michael S. Harper (10305205), Valentin Voillet (3444920), Nicole Grunenberg (662181), Fatima Laher (238017), Craig Innes (662182), Linda-Gail Bekker (60754), James G. Kublin (8173401), Ying Huang (53474), Guido Ferrari (164054), Georgia D. Tomaras (7163792), Glenda Gray (64254), Peter B. Gilbert (7431215), M. Juliana McElrath (8048912)
مصطلحات موضوعية: Medicine, Microbiology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Computational Biology, 4- dose regimen, HVTN, pox-protein regimen, RV 144 regimen, Days 3, vaccine efficacy, ALVAC-HIV immunization, guide efforts, 1 day post-vaccination, day 1 signatures, transcriptional signatures, II interferon, vaccine strategy, Month 6.5, vaccine regimens, Subsequent analyses, vaccine-induced protection, phagocytosis activity, partially-efficacious HIV vaccine, HIV infection, acquisition risk, Months 6.5
-
4دورية أكاديمية
المؤلفون: Erica Andersen-Nissen (8881685), Andrew Fiore-Gartland (849286), Lamar Ballweber Fleming (10305199), Lindsay N. Carpp (8048906), Anneta F. Naidoo (10305202), Michael S. Harper (10305205), Valentin Voillet (3444920), Nicole Grunenberg (662181), Fatima Laher (238017), Craig Innes (662182), Linda-Gail Bekker (60754), James G. Kublin (8173401), Ying Huang (53474), Guido Ferrari (164054), Georgia D. Tomaras (7163792), Glenda Gray (64254), Peter B. Gilbert (7431215), M. Juliana McElrath (8048912)
مصطلحات موضوعية: Medicine, Microbiology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Computational Biology, 4- dose regimen, HVTN, pox-protein regimen, RV 144 regimen, Days 3, vaccine efficacy, ALVAC-HIV immunization, guide efforts, 1 day post-vaccination, day 1 signatures, transcriptional signatures, II interferon, vaccine strategy, Month 6.5, vaccine regimens, Subsequent analyses, vaccine-induced protection, phagocytosis activity, partially-efficacious HIV vaccine, HIV infection, acquisition risk, Months 6.5
-
5دورية أكاديمية
المؤلفون: Erica Andersen-Nissen (8881685), Andrew Fiore-Gartland (849286), Lamar Ballweber Fleming (10305199), Lindsay N. Carpp (8048906), Anneta F. Naidoo (10305202), Michael S. Harper (10305205), Valentin Voillet (3444920), Nicole Grunenberg (662181), Fatima Laher (238017), Craig Innes (662182), Linda-Gail Bekker (60754), James G. Kublin (8173401), Ying Huang (53474), Guido Ferrari (164054), Georgia D. Tomaras (7163792), Glenda Gray (64254), Peter B. Gilbert (7431215), M. Juliana McElrath (8048912)
مصطلحات موضوعية: Medicine, Microbiology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Computational Biology, 4- dose regimen, HVTN, pox-protein regimen, RV 144 regimen, Days 3, vaccine efficacy, ALVAC-HIV immunization, guide efforts, 1 day post-vaccination, day 1 signatures, transcriptional signatures, II interferon, vaccine strategy, Month 6.5, vaccine regimens, Subsequent analyses, vaccine-induced protection, phagocytosis activity, partially-efficacious HIV vaccine, HIV infection, acquisition risk, Months 6.5
-
6دورية أكاديمية
المؤلفون: Erica Andersen-Nissen (8881685), Andrew Fiore-Gartland (849286), Lamar Ballweber Fleming (10305199), Lindsay N. Carpp (8048906), Anneta F. Naidoo (10305202), Michael S. Harper (10305205), Valentin Voillet (3444920), Nicole Grunenberg (662181), Fatima Laher (238017), Craig Innes (662182), Linda-Gail Bekker (60754), James G. Kublin (8173401), Ying Huang (53474), Guido Ferrari (164054), Georgia D. Tomaras (7163792), Glenda Gray (64254), Peter B. Gilbert (7431215), M. Juliana McElrath (8048912)
مصطلحات موضوعية: Medicine, Microbiology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Computational Biology, 4- dose regimen, HVTN, pox-protein regimen, RV 144 regimen, Days 3, vaccine efficacy, ALVAC-HIV immunization, guide efforts, 1 day post-vaccination, day 1 signatures, transcriptional signatures, II interferon, vaccine strategy, Month 6.5, vaccine regimens, Subsequent analyses, vaccine-induced protection, phagocytosis activity, partially-efficacious HIV vaccine, HIV infection, acquisition risk, Months 6.5
-
7دورية أكاديمية
المؤلفون: Erica Andersen-Nissen (8881685), Andrew Fiore-Gartland (849286), Lamar Ballweber Fleming (10305199), Lindsay N. Carpp (8048906), Anneta F. Naidoo (10305202), Michael S. Harper (10305205), Valentin Voillet (3444920), Nicole Grunenberg (662181), Fatima Laher (238017), Craig Innes (662182), Linda-Gail Bekker (60754), James G. Kublin (8173401), Ying Huang (53474), Guido Ferrari (164054), Georgia D. Tomaras (7163792), Glenda Gray (64254), Peter B. Gilbert (7431215), M. Juliana McElrath (8048912)
مصطلحات موضوعية: Medicine, Microbiology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Computational Biology, 4- dose regimen, HVTN, pox-protein regimen, RV 144 regimen, Days 3, vaccine efficacy, ALVAC-HIV immunization, guide efforts, 1 day post-vaccination, day 1 signatures, transcriptional signatures, II interferon, vaccine strategy, Month 6.5, vaccine regimens, Subsequent analyses, vaccine-induced protection, phagocytosis activity, partially-efficacious HIV vaccine, HIV infection, acquisition risk, Months 6.5
-
8دورية أكاديمية
المؤلفون: Erica Andersen-Nissen (8881685), Andrew Fiore-Gartland (849286), Lamar Ballweber Fleming (10305199), Lindsay N. Carpp (8048906), Anneta F. Naidoo (10305202), Michael S. Harper (10305205), Valentin Voillet (3444920), Nicole Grunenberg (662181), Fatima Laher (238017), Craig Innes (662182), Linda-Gail Bekker (60754), James G. Kublin (8173401), Ying Huang (53474), Guido Ferrari (164054), Georgia D. Tomaras (7163792), Glenda Gray (64254), Peter B. Gilbert (7431215), M. Juliana McElrath (8048912)
مصطلحات موضوعية: Medicine, Microbiology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Computational Biology, 4- dose regimen, HVTN, pox-protein regimen, RV 144 regimen, Days 3, vaccine efficacy, ALVAC-HIV immunization, guide efforts, 1 day post-vaccination, day 1 signatures, transcriptional signatures, II interferon, vaccine strategy, Month 6.5, vaccine regimens, Subsequent analyses, vaccine-induced protection, phagocytosis activity, partially-efficacious HIV vaccine, HIV infection, acquisition risk, Months 6.5
-
9دورية أكاديمية
المؤلفون: Erica Andersen-Nissen (8881685), Andrew Fiore-Gartland (849286), Lamar Ballweber Fleming (10305199), Lindsay N. Carpp (8048906), Anneta F. Naidoo (10305202), Michael S. Harper (10305205), Valentin Voillet (3444920), Nicole Grunenberg (662181), Fatima Laher (238017), Craig Innes (662182), Linda-Gail Bekker (60754), James G. Kublin (8173401), Ying Huang (53474), Guido Ferrari (164054), Georgia D. Tomaras (7163792), Glenda Gray (64254), Peter B. Gilbert (7431215), M. Juliana McElrath (8048912)
مصطلحات موضوعية: Medicine, Microbiology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Computational Biology, 4- dose regimen, HVTN, pox-protein regimen, RV 144 regimen, Days 3, vaccine efficacy, ALVAC-HIV immunization, guide efforts, 1 day post-vaccination, day 1 signatures, transcriptional signatures, II interferon, vaccine strategy, Month 6.5, vaccine regimens, Subsequent analyses, vaccine-induced protection, phagocytosis activity, partially-efficacious HIV vaccine, HIV infection, acquisition risk, Months 6.5
-
10دورية أكاديمية
المؤلفون: Erica Andersen-Nissen (8881685), Andrew Fiore-Gartland (849286), Lamar Ballweber Fleming (10305199), Lindsay N. Carpp (8048906), Anneta F. Naidoo (10305202), Michael S. Harper (10305205), Valentin Voillet (3444920), Nicole Grunenberg (662181), Fatima Laher (238017), Craig Innes (662182), Linda-Gail Bekker (60754), James G. Kublin (8173401), Ying Huang (53474), Guido Ferrari (164054), Georgia D. Tomaras (7163792), Glenda Gray (64254), Peter B. Gilbert (7431215), M. Juliana McElrath (8048912)
مصطلحات موضوعية: Medicine, Microbiology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Computational Biology, 4- dose regimen, HVTN, pox-protein regimen, RV 144 regimen, Days 3, vaccine efficacy, ALVAC-HIV immunization, guide efforts, 1 day post-vaccination, day 1 signatures, transcriptional signatures, II interferon, vaccine strategy, Month 6.5, vaccine regimens, Subsequent analyses, vaccine-induced protection, phagocytosis activity, partially-efficacious HIV vaccine, HIV infection, acquisition risk, Months 6.5